Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Preferred Shares (2021 - 2025)

Historic Preferred Shares for Coeptis Therapeutics Holdings (COEP) over the last 3 years, with Q2 2025 value amounting to $1.0.

  • Coeptis Therapeutics Holdings' Preferred Shares changed N/A to $1.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.0, marking a year-over-year change of. This contributed to the annual value of $2.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Coeptis Therapeutics Holdings' Preferred Shares is $1.0.
  • Coeptis Therapeutics Holdings' 5-year Preferred Shares high stood at $2.0 for Q3 2024, and its period low was $1.0 during Q4 2021.
  • Its 3-year average for Preferred Shares is $1.4, with a median of $1.0 in 2021.